The efficacy and predictive factors of response of second line triplet (modified-EOX; epirubicin-oxaliplatin-capacitabine) regimen in metastatic gastric cancer


Sendur M. A. N., Ozdemir N., Aksoy S., Yazici O., Yazilitas D., Akinci M. B., ...More

European Cancer Congress, Vienna, Austria, 01 January 2015, vol.51, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 51
  • Doi Number: 10.1016/s0959-8049(16)31266-7
  • City: Vienna
  • Country: Austria
  • Hacettepe University Affiliated: Yes